Immunohistochemical staining revealed that NDV+liposomal doxorubicin‐treated tumours expressed higher P53 due to increased apoptotic and necrotic tumour cells and lower Ki67 expression as proliferative markers (Figure 5II). The gene discussed is MKI67; the disease is neoplasm.